Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation

Author： Brazelton T.R. Adams B.A. Cheung A.C. Morris R.E.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.29, Iss.6, 1997-09, pp. : 2613-2613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Administration of exogenous interleukin-2 enhances obliterative airway disease in cyclosporine-treated rats following tracheal allografts

By Takao M. Gu Y. Shimamoto A. Adachi K. Namikawa S. Yada I.

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 180-181

Elsevier

Access to resources Recommend Favorite

Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease

By Yonan N.A. Bishop P. El-Gamel A. Hutchinson I.V.

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2207-2209

Elsevier

Access to resources Recommend Favorite

Interaction of TGF-&bgr; with Immune Cells in Airway Disease

Current Molecular Medicine, Vol. 8, Iss. 5, 2008-08 ,pp. : 427-436

Bentham Science Publishers

Access to resources Recommend Favorite

CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas

By Kita Y. Li X.-K. Nogimura H. Ida M. Kageyama Y. Ohi S. Suzuki K. Kazui T. Suzuki S.

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 458-460

Elsevier

Access to resources Recommend Favorite

Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection

By Brazelton T.R. Shorthouse R. Huang X. Morris R.E.

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2614-2614

Elsevier

Access to resources Recommend Favorite